The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for structural heart disease
TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)
Alexander Lauten1*, MD; Hans R. Figulla2, MD; Helge Möllmann2, MD; David Holzhey3, MD; Joachim Kötting4, MSc; Andreas Beckmann5, MD; Christof Veit4, MD; Jochen Cremer6, MD; Karl-Heinz Kuck7, MD; Rüdiger Lange8, MD; Ralf Zahn9, MD; Stefan Sack10, MD; Gerhard Schuler3, MD; Thomas Walther11, MD; Friedhelm Beyersdorf
1. Department of Internal Medicine I, University Heart Center Jena, Jena, Germany; 2. Department of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany; 3. Leipzig Heart Center, University of Leipzig, Leipzig, Germany; 4. BQS Institute for Quality and Pati
Aims: The study analyses the outcome of patients undergoing transcatheter aortic valve implantation (TAVI) for different subtypes of severe aortic stenosis (AS) based on data from the GAR
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
paradoxical low-gradient aortic stenosistranscatheter aortic valve replacement
Read next article
Percutaneous reclosure of a patent foramen ovale after bioabsorbable device implantation